The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision
Open accessAbstract
Objective: To revise the 2010 consensus guideline on chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Methods: Seventeen disease experts, a patient representative, and two Cochrane methodologists constructed 12 Population/Intervention/Comparison/Outcome (PICO) questions regarding diagnosis and treatment to guide the literature search. Data were extracted and summarized in GRADE summary of findings (for treatment PICOs) or evidence tables (for diagnostic PICOs). Results: Statements were prepared according to the GRADE Evidence‐to‐Decision frameworks. Typical CIDP and CIDP variants were distinguished. The previous term “atypical CIDP” was replaced by “CIDP variants” because these are well characterized entities (multifocal, focal, distal, motor, or sensory CIDP). The levels of diagnostic certainty were reduced from three (definite, probable, possible CIDP) to only two (CIDP and possible CIDP), because the diagnostic accuracy of criteria for probable and definite CIDP did not significantly differ. Good Practice Points were formulated for supportive criteria and investigations to be considered to diagnose CIDP. The principal treatment recommendations were: (a) intravenous immunoglobulin (IVIg) or corticosteroids are strongly recommended as initial treatment in typical CIDP and CIDP variants; (b) plasma exchange is strongly recommended if IVIg and corticosteroids are ineffective; (c) IVIg should be considered as first‐line treatment in motor CIDP (Good Practice Point); (d) for maintenance treatment, IVIg, subcutaneous immunoglobulin or corticosteroids are recommended; (e) if the maintenance dose of any of these is high, consider either combination treatments or adding an immunosuppressant or immunomodulatory drug (Good Practice Point); and (f) if pain is present, consider drugs against neuropathic pain and multidisciplinary management (Good Practice Point).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980
AGREE II: advancing guideline development, reporting and evaluation in health care
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Grimshaw, J., Hanna, S. E., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.090449 · Cited by 3,790
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Andrews, J. C., Schünemann, H. J., Oxman, A. D., Pottie, K., Meerpohl, J. J., Coello, P. A., Rind, D., Montori, V. M., Brito, J. P., Norris, S., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.003 · Cited by 1,315
Alonso-Coello, P., Oxman, A. D., Moberg, J., Brignardello-Petersen, R., Akl, E. A., Davoli, M., Treweek, S., Mustafa, R. A., Vandvik, P. O., Meerpohl, J., et al. (2016) · BMJ · doi:10.1136/bmj.i2089 · Cited by 814
AGREE II: advancing guideline development, reporting, and evaluation in health care
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Grimshaw, J., Hanna, S. E., et al. (2010) · Preventive Medicine · doi:10.1016/j.ypmed.2010.08.005 · Cited by 758
Hughes, R. A., Donofrio, P., Bril, V., Dalakas, M. C., Deng, C., Hanna, K., Hartung, H.-P., Latov, N., Merkies, I. S., & van Doorn, P. A. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70329-0 · Cited by 674
Self-citationJoint Task Force of the EFNS and the PNS (2010) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2010.00290.x · Cited by 568
Joint Task Force of the EFNS and the PNS (2010) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2010.00245.x · Cited by 539
Multifocal demyelinating neuropathy with persistent conduction block
Lewis, R. A., Sumner, A. J., Brown, M. J., & Asbury, A. K. (1982) · Neurology · doi:10.1212/wnl.32.9.958 · Cited by 502
Self-citationPlasma Exchange in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Dyck, P. J., Daube, J., O'Brien, P., Pineda, A., Low, P. A., Windebank, A. J., & Swanson, C. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140801 · Cited by 489
Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment
Dyck, P. J., O'Brien, P. C., Oviatt, K. F., Dinapoli, R. P., Daube, J. R., Bartleson, J. D., Mokri, B., Swift, T., Low, P. A., & Windebank, A. J. (1982) · Annals of Neurology · doi:10.1002/ana.410110205 · Cited by 483
Dyck, P. J., Litchy, W. J., Kratz, K. M., Suarez, G. A., Low, P. A., Pineda, A. A., Windebank, A. J., Karnes, J. L., & O'Brien, P. C. (1994) · Annals of Neurology · doi:10.1002/ana.410360607 · Cited by 471
Hahn, A. F., Bolton, C. F., Pillay, N., Chalk, C., Benstead, T. J., Bril, V., Shumak, K. H., Vandervoort, M. K., & Feasby, T. E. (1996) · Brain · doi:10.1093/brain/119.4.1055 · Cited by 409
Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies
van Nes, S. I., Vanhoutte, E. K., van Doorn, P. A., Hermans, M., Bakkers, M., Kuitwaard, K., Faber, C. G., & Merkies, I. S. J. (2011) · Neurology · doi:10.1212/wnl.0b013e318208824b · Cited by 381
Self-citationNeurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg
Querol, L., Nogales-Gadea, G., Rojas-Garcia, R., Diaz-Manera, J., Pardo, J., Ortega-Moreno, A., Sedano, M. J., Gallardo, E., Berciano, J., Blesa, R., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000205 · Cited by 370
Self-citationChronic relapsing polyneuritis
Prineas, J. W., & McLeod, J. G. (1976) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(76)90213-6 · Cited by 368
Antibodies to contactin‐1 in chronic inflammatory demyelinating polyneuropathy
Querol, L., Nogales‐Gadea, G., Rojas‐Garcia, R., Martinez‐Hernandez, E., Diaz‐Manera, J., Suárez‐Calvet, X., Navas, M., Araque, J., Gallardo, E., & Illa, I. (2013) · Annals of Neurology · doi:10.1002/ana.23794 · Cited by 352
Self-citationSchünemann, H. J., Mustafa, R., Brozek, J., Santesso, N., Alonso-Coello, P., Guyatt, G., Scholten, R., Langendam, M., Leeflang, M. M., Akl, E. A., et al. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.01.032 · Cited by 350
Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies
Merkies, I. S. J. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.5.596 · Cited by 311
Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy
Bouchard, C., Lacroix, C., Planté, V., Adams, D., Chedru, F., Guglielmi, J.-M., & Said, G. (1999) · Neurology · doi:10.1212/wnl.52.3.498 · Cited by 294
Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy
Devaux, J. J., Miura, Y., Fukami, Y., Inoue, T., Manso, C., Belghazi, M., Sekiguchi, K., Kokubun, N., Ichikawa, H., Wong, H. Y., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002418 · Cited by 293
van Schaik, I. N., Bril, V., van Geloven, N., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30378-2 · Cited by 281
Mycophenolate mofetil: A safe and promising immunosuppressant in neuromuscular diseases
Chaudhry, V., Cornblath, D. R., Griffin, J. W., O’Brien, R., & Drachman, D. B. (2001) · Neurology · doi:10.1212/wnl.56.1.94 · Cited by 259
Self-citationElectrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy
Van Den Bergh, P. Y. K., & Piéret, F. (2004) · Muscle & Nerve · doi:10.1002/mus.20022 · Cited by 251
Self-citationHughes, R. A. C., Bouche, P., Cornblath, D. R., Evers, E., Hadden, R. D. M., Hahn, A., Illa, I., Koski, C. L., Léger, J. M., Nobile‐Orazio, E., et al. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01278.x · Cited by 246
Self-citationGuideline panels should seldom make good practice statements: guidance from the GRADE Working Group
Guyatt, G. H., Alonso-Coello, P., Schünemann, H. J., Djulbegovic, B., Nothacker, M., Lange, S., Murad, M. H., & Akl, E. A. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.07.006 · Cited by 243
Lunn, M. P., & Nobile-Orazio, E. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002827.pub4 · Cited by 235
Self-citationCombined azathioprine and prednisone in chronic inflammatory‐demyelinating polyneuropathy
Dyck, P. J., O'Brien, P., Swanson, C., Low, P., & Daube, J. (1985) · Neurology · doi:10.1212/wnl.35.8.1173 · Cited by 227
Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications
Querol, L., Devaux, J., Rojas-Garcia, R., & Illa, I. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.84 · Cited by 227
Self-citationContactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia
Miura, Y., Devaux, J. J., Fukami, Y., Manso, C., Belghazi, M., Wong, A. H. Y., Yuki, N., & for the CNTN1-CIDP Study Group (2015) · Brain · doi:10.1093/brain/awv054 · Cited by 223
Nobile-Orazio, E., Cocito, D., Jann, S., Uncini, A., Beghi, E., Messina, P., Antonini, G., Fazio, R., Gallia, F., Schenone, A., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70093-5 · Cited by 223
Self-citationvan Schaik, I. N., Eftimov, F., van Doorn, P. A., Brusse, E., van den Berg, L. H., van der Pol, W. L., Faber, C. G., van Oostrom, J. C., Vogels, O. J., Hadden, R. D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70021-1 · Cited by 219
Self-citationIntravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy
Eftimov, F., Winer, J. B., Vermeulen, M., de Haan, R., & van Schaik, I. N. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001797.pub2 · Cited by 216
Self-citationPsychometric evaluation of a new sensory scale in immune-mediated polyneuropathies
Merkies, I. S. J., Schmitz, P. I. M., van der Meché, F. G. A., & van Doorn, P. A. (2000) · Neurology · doi:10.1212/wnl.54.4.943 · Cited by 215
Self-citationDyck, P. J., Boes, C. J., Mulder, D., Millikan, C., Windebank, A. J., Dyck, P. J. B., & Espinosa, R. (2005) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2005.0010206.x · Cited by 213
Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy
Mehndiratta, M. M., Hughes, R. A., & Pritchard, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003906.pub4 · Cited by 210
Doppler, K., Appeltshauser, L., Villmann, C., Martin, C., Peles, E., Krämer, H. H., Haarmann, A., Buttmann, M., & Sommer, C. (2016) · Brain · doi:10.1093/brain/aww189 · Cited by 210
Self-citationCharacterization of IgG4 anti‐neurofascin 155 antibody‐positive polyneuropathy
Ogata, H., Yamasaki, R., Hiwatashi, A., Oka, N., Kawamura, N., Matsuse, D., Kuwahara, M., Suzuki, H., Kusunoki, S., Fujimoto, Y., et al. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.248 · Cited by 208
Chronic immune sensory polyradiculopathy: A possibly treatable sensory ataxia
Sinnreich, M., Klein, C. J., Daube, J. R., Engelstad, J., Spinner, R. J., & Dyck, P. J. B. (2004) · Neurology · doi:10.1212/01.wnl.0000142507.12763.58 · Cited by 207
Oaklander, A. L., Lunn, M. P., Hughes, R. A., van Schaik, I. N., Frost, C., & Chalk, C. H. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010369.pub2 · Cited by 199
Self-citationJoint Task Force of the EFNS and the PNS (2005) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2005.10302.x · Cited by 182
Cortese, A., Lombardi, R., Briani, C., Callegari, I., Benedetti, L., Manganelli, F., Luigetti, M., Ferrari, S., Clerici, A. M., Marfia, G. A., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000639 · Cited by 182
Self-citationDiagnostic value of sonography in treatment-naive chronic inflammatory neuropathies
Goedee, H. S., van der Pol, W. L., van Asseldonk, J.-T. H., Franssen, H., Notermans, N. C., Vrancken, A. J. F. E., van Es, M. A., Nikolakopoulos, S., Visser, L. H., & van den Berg, L. H. (2017) · Neurology · doi:10.1212/wnl.0000000000003483 · Cited by 170
Self-citationIntravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy
Eftimov, F., Winer, J. B., Vermeulen, M., de Haan, R., & van Schaik, I. N. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001797.pub3 · Cited by 165
Self-citationUltrasound of inherited vs. acquired demyelinating polyneuropathies
Zaidman, C. M., Harms, M. B., & Pestronk, A. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7123-8 · Cited by 163
Randomized trial of interferon β-1a in chronic inflammatory demyelinating polyradiculoneuropathy
Hadden, R. D. M., Sharrack, B., Bensa, S., Soudain, S., & Hughes, R. A. (1999) · Neurology · doi:10.1212/wnl.53.1.57 · Cited by 156
Self-citationAdverse events in apheresis: An update of the WAA registry data
Henriksson, M. M., Newman, E., Witt, V., Derfler, K., Leitner, G. C., Eloot, S., Dhondt, A., Deeren, D., Rock, G. A., Ptak, J., et al. (2016) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2016.01.003 · Cited by 156
Distinguishing acute-onset CIDP from Guillain–Barré syndrome with treatment related fluctuations
Ruts, L., van Koningsveld, R., & van Doorn, P. A. (2005) · Neurology · doi:10.1212/01.wnl.0000167549.09664.b8 · Cited by 151
Simmons, Z., Albers, J. W., Bromberg, M. B., & Feldman, E. L. (1993) · Neurology · doi:10.1212/wnl.43.11.2202 · Cited by 149
Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy
Good, J. L., Chehrenama, M., Mayer, R. F., & Koski, C. L. (1998) · Neurology · doi:10.1212/wnl.51.6.1735 · Cited by 142
Bromberg, M. B., & Albers, J. W. (1993) · Muscle & Nerve · doi:10.1002/mus.880160304 · Cited by 135
Vural, A., Doppler, K., & Meinl, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01029 · Cited by 134
Maisonobe, T., Chassande, B., Vérin, M., Jouni, M., Léger, J., & Bouché, P. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.1.36 · Cited by 126
Sural Nerve Donor-Site Morbidity
IJpma, F. F. A., Nicolai, J. A., & Meek, M. F. (2006) · Annals of Plastic Surgery · doi:10.1097/01.sap.0000221963.66229.b6 · Cited by 125
Mowzoon, N., Sussman, A. T., & Bradley, W. G. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00478-6 · Cited by 124
Childhood chronic inflammatory demyelinating neuropathies
Nevo, Y., Pestronk, A., Kornberg, A. J., Connolly, A. M., Yee, W.-C., Iqbal, I., & Shield, L. K. (1996) · Neurology · doi:10.1212/wnl.47.1.98 · Cited by 108
Childhood chronic inflammatory demyelinating polyneuropathy: clinical course and long-term outcome
Ryan, M. M., Grattan‐Smith, P. J., Procopis, P. G., Morgan, G., & Ouvrier, R. (2000) · Neuromuscular Disorders · doi:10.1016/s0960-8966(00)00119-x · Cited by 105
Age of onset influences clinical features of chronic inflammatory demyelinating polyneuropathy
Hattori, N., Misu, K., Koike, H., Ichimura, M., Nagamatsu, M., Hirayama, M., & Sobue, G. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00493-7 · Cited by 95
Vanhoutte, E. K., Latov, N., Deng, C. Q., Hanna, K., Hughes, R. A., Bril, V., Dalakas, M. C., Donofrio, P. D., van Doorn, P. A., Hartung, H., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03851.x · Cited by 94
Immune checkpoint inhibitors‐induced neuromuscular toxicity: From pathogenesis to treatment
Psimaras, D., Velasco, R., Birzu, C., Tamburin, S., Lustberg, M. B., Bruna, J., & Argyriou, A. A. (2019) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12339 · Cited by 94
Merkies, I. S. J., van Nes, S. I., Hanna, K., Hughes, R. A., & Deng, C. Q. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.194324 · Cited by 87
Velasco, R., Alberti, P., Bruna, J., Psimaras, D., & Argyriou, A. A. (2019) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12338 · Cited by 87
Painless diabetic motor neuropathy: A variant of diabetic lumbosacral radiculoplexus Neuropathy?
Garcés‐Sánchez, M., Laughlin, R. S., Dyck, P. J., Engelstad, J. K., Norell, J. E., & Dyck, P. J. (2010) · Annals of Neurology · doi:10.1002/ana.22334 · Cited by 86
Treatment of chronic inflammatory demyelinating polyneuropathy with cyclosporin-A.
Mahattanakul, W., Crawford, T. O., Griffin, J. W., Goldstein, J. M., & Cornblath, D. R. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.2.185 · Cited by 81
Self-citationAlemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy
Marsh, E. A., Hirst, C. L., Llewelyn, J., Cossburn, M., Reilly, M. M., Krishnan, A., Doran, M., Ryan, A., Coles, A. J., Jones, J., et al. (2010) · Journal of Neurology · doi:10.1007/s00415-009-5437-3 · Cited by 80
Diagnostic accuracy of MRI and ultrasound in chronic immune-mediated neuropathies
Oudeman, J., Eftimov, F., Strijkers, G. J., Schneiders, J. J., Roosendaal, S. D., Engbersen, M. P., Froeling, M., Goedee, H. S., van Doorn, P. A., Caan, M. W. A., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008697 · Cited by 78
Self-citationGladstone, D. E., Prestrud, A. A., & Brannagan, T. H. (2005) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2005.10104.x · Cited by 73
Theriault, M., Dort, J. C., Sutherland, G. R., & Zochodne, D. W. (1998) · Neurology · doi:10.1212/wnl.50.2.480 · Cited by 72
Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy
Mahdi‐Rogers, M., Kazmi, M. A., Ferner, R. E., Hughes, R. A., Renaud, S., Steck, A. J., Fuhr, P., Halter, J. P., Gratwohl, A. A., & Tyndall, A. (2009) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2009.00221.x · Cited by 64
Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP
Press, R., Askmark, H., Svenningsson, A., Andersen, O., Axelson, H. W., Strömberg, U., Wåhlin, A., Isaksson, C., Johansson, J.-E. J., & Hägglund, H. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306014 · Cited by 63
Matsuda, M., Hoshi, K., Gono, T., Morita, H., & Ikeda, S. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.05.014 · Cited by 55
Dahlin, L. B., Eriksson, K., & Sundkvist, G. (1997) · Diabetic Medicine · Cited by 55
Assessment of hand function in a patient with chronic sensory demyelinating neuropathy
Thonnard, J., Detrembleur, C., & den Bergh, P. Y. K. V. (1997) · Neurology · doi:10.1212/wnl.49.1.253 · Cited by 49
Doneddu, P. E., Bianchi, E., Cocito, D., Manganelli, F., Fazio, R., Filosto, M., Mazzeo, A. T., Cosentino, G., Cortese, A., Jann, S., et al. (2019) · European Journal of Neurology · doi:10.1111/ene.14044 · Cited by 47
Self-citationLeone, M. A., Keindl, M., Schapira, A. H. V., Deuschl, G., & Federico, A. (2015) · European Journal of Neurology · doi:10.1111/ene.12818 · Cited by 46
Tanaka, K., Mori, N., Yokota, Y., & Suenaga, T. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003443 · Cited by 44
Marsh, E. A., Keddie, S., Terris‐Prestholt, F., D’Sa, S., & Lunn, M. P. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-324012 · Cited by 43
Self-citationLiberatore, G., Giannotta, C., Sajeev, B. P., et al. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577288 · Cited by 39
Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy
Pascual‐Goñi, E., Aguilar, L., Lleixà, C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42545-8 · Cited by 37
Verma, A., Tandan, R., Adesina, A. M., et al. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1990.tb01011.x · Cited by 34
Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy
Kuitwaard, K., Fokkink, W. R., Brusse, E., Vrancken, A. F. J. E., Eftimov, F., Notermans, N. C., van der Kooi, A. J., Merkies, I. S. J., Jacobs, B. C., & van Doorn, P. A. (2017) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12242 · Cited by 32
Self-citationMichaelides, A., Hadden, R. D. M., Sarrigiannis, P. G., Hadjivassiliou, M., & Zis, P. (2019) · Pain and Therapy · doi:10.1007/s40122-019-0128-y · Cited by 32
Self-citationMitsuma, S., den Bergh, P. Y. K. V., Rajabally, Y. A., Parijs, V. V., Martin-Lamb, D., Sonoo, M., Inaba, A., Shimizu, T., Isose, S., Sato, Y., et al. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.11.027 · Cited by 30
Self-citationHead and voice tremor improving with immunotherapy in an anti‐ NF 155 positive CIDP patient
Painous, C., López‐Pérez, M. A., Illa, I., & Querol, L. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.539 · Cited by 27
Self-citationRajabally, Y. A., & Ghasemi, M. (2019) · Muscle & Nerve · doi:10.1002/mus.26747 · Cited by 26
Self-citationvan Rosmalen, M. H. J., Goedee, H. S., van der Gijp, A., et al. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10232-8 · Cited by 20
Self-citationAlkhawajah, N. M., Dunnigan, S. K., & Bril, V. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7357-0 · Cited by 19
Sakamoto, Y., Shimizu, T., Tobisawa, S., et al. (2017) · Neurological Sciences · doi:10.1007/s10072-017-3133-0 · Cited by 18
Bjelica, B., Perić, S., Božović, I., Kačar, A., Cobeljic, M., Dejanović, I., Stević, Z., & Basta, I. Z. (2019) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12318 · Cited by 14
Pain in acquired inflammatory demyelinating polyneuropathies
Thakur, S., Dworkin, R. H., Freeman, R. L., Gorson, K. C., & Herrmann, D. N. (2016) · Pain · doi:10.1097/j.pain.0000000000000539 · Cited by 10
Cited by
Connelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
Lappalainen, P., Keinonen, K., Lappalainen, R., Selinheimo, S., Vuokko, A., Sainio, M., Liesto, S., Tolvanen, A., & Paunio, T. (2024) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2024.111830 · Cited by 17
Metadata
- Authors
- Van den Bergh, P. Y. K., van Doorn, P. A., Hadden, R. D. M., Avau, B., Vankrunkelsven, P., Allen, J. A., Attarian, S., Blomkwist‐Markens, P. H., Cornblath, D. R., Eftimov, F., Goedee, H. S., Harbo, T., Kuwabara, S., Lewis, R. A., Lunn, M. P., Nobile‐Orazio, E., Querol, L., Rajabally, Y. A., Sommer, C., & Topaloglu, H. A.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2021-07-30
- Volume
- 28
- Issue
- 11
- Pages
- 3556-3583
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W3186729348
- Cited by
- 530
- References
- 91
- FWCI
- 26.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.